ATE460474T1 - Verwendung einer soja zelllinie mit hohem isoflavon gehalt - Google Patents

Verwendung einer soja zelllinie mit hohem isoflavon gehalt

Info

Publication number
ATE460474T1
ATE460474T1 AT02009810T AT02009810T ATE460474T1 AT E460474 T1 ATE460474 T1 AT E460474T1 AT 02009810 T AT02009810 T AT 02009810T AT 02009810 T AT02009810 T AT 02009810T AT E460474 T1 ATE460474 T1 AT E460474T1
Authority
AT
Austria
Prior art keywords
cell line
isoflavone content
high isoflavone
soya
soy cell
Prior art date
Application number
AT02009810T
Other languages
English (en)
Inventor
Ermanno Federici
Andre Touche
Didier Courtois
Vincent Petiard
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE460474T1 publication Critical patent/ATE460474T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
AT02009810T 2002-04-30 2002-04-30 Verwendung einer soja zelllinie mit hohem isoflavon gehalt ATE460474T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02009810A EP1359215B1 (de) 2002-04-30 2002-04-30 Verwendung einer Soja Zelllinie mit hohem Isoflavon Gehalt

Publications (1)

Publication Number Publication Date
ATE460474T1 true ATE460474T1 (de) 2010-03-15

Family

ID=28799673

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02009810T ATE460474T1 (de) 2002-04-30 2002-04-30 Verwendung einer soja zelllinie mit hohem isoflavon gehalt

Country Status (9)

Country Link
US (1) US7354765B2 (de)
EP (2) EP1359215B1 (de)
JP (1) JP4343828B2 (de)
AT (1) ATE460474T1 (de)
AU (1) AU2003227617B2 (de)
CA (1) CA2484258A1 (de)
DE (1) DE60235610D1 (de)
NO (1) NO20045212L (de)
WO (1) WO2003093456A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2420279T3 (es) * 2000-03-02 2013-08-23 Microchips, Inc. Dispositivos microfabricados y métodos para almacenamiento y exposición selectiva de productos químicos
JP2007520230A (ja) * 2004-02-06 2007-07-26 コンク ユニヴァーシティ インダストリアル コーペレーション コープ 高濃度イソフラボンを含む発芽豆及びその製造方法
US20140087026A1 (en) * 2012-09-26 2014-03-27 Dianaplantsciences, S.A.S. Novel food composition of whole plant cells
CN106028795B (zh) * 2013-12-13 2020-03-03 庆尚大学校产学协力团 具有高含量异黄酮衍生物的豆叶或豆茎及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992375A (en) * 1983-11-25 1991-02-12 Monsanto Company Method of regenerating soybeans from cultured soybean cotyledonary nodes
JPH05176756A (ja) 1991-12-27 1993-07-20 Idemitsu Kosan Co Ltd Va菌根菌製剤の保存方法
US5702752A (en) 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
US5821361A (en) 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses

Also Published As

Publication number Publication date
US20050050589A1 (en) 2005-03-03
DE60235610D1 (de) 2010-04-22
CA2484258A1 (en) 2003-11-13
JP4343828B2 (ja) 2009-10-14
EP1501919A1 (de) 2005-02-02
JP2005523721A (ja) 2005-08-11
AU2003227617A1 (en) 2003-11-17
EP1359215B1 (de) 2010-03-10
NO20045212L (no) 2005-01-28
WO2003093456A1 (en) 2003-11-13
EP1359215A1 (de) 2003-11-05
US7354765B2 (en) 2008-04-08
AU2003227617B2 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
ATE415478T1 (de) Fermentationsverfahren zur herstellung von l- aminosäuren unter verwendung von stämmen aus der familie der enterobacteriaceae
DE60113744D1 (de) Verfahren zur Herstellung von Ethanol aus Lignocellulose-haltiger Biomasse unter Verwendung von thermostabiler Hefe
DE502004004552D1 (de) Flammenhydrolytisch hergestelltes Siliciumdioxid, Verfahren zu seiner Herstellung und Verwendung
ATE506356T1 (de) Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
GB0308407D0 (en) Method of obtaining 68 GA
ATE356084T1 (de) Verfahren zur herstellung eines silicoaluminophosphat-molekularsiebs
ATE349412T1 (de) Epothilon-synthesebausteine i: unsymmetrisch substituierte acyloine und acyloinderivate, verfahren zu deren herstellung sowie deren verwendung zur herstellung von epothilonen und epothilonderivaten
UA89390C2 (ru) Способ получения аннелированных производных пиперазин-2-она та соответствующие промежуточные продукты
ATE423756T1 (de) Verfahren zur herstellung von hochreinem methyl- tert.-butylether
BR0202518A (pt) Método para produção de uma composição, composição, e, método para aderir um material a um substrato
WO2002051985A3 (en) Culturing tissue using magnetically generated mechanical stresses
ATE332304T1 (de) Cefdinir salze als zwischenprodukte
ATE553210T1 (de) Verfahren zur herstellung von l-threonin unter verwendung eines mikroorganismus mit inaktivierten galr gen.
ATE486857T1 (de) Verfahren zur herstellung von telmisartan
ATE452180T1 (de) Blakeslea trispora zur herstellung von lycopin in hoher ausbeute, in einem geeigneten medium in abwesenheit eines exogenen corotenogenese- hemmstoffes
DE60235610D1 (de) Verwendung einer Soja Zelllinie mit hohem Isoflavon Gehalt
DE502006000347D1 (de) Oberflächenbelegte perlglanzpigmente, verfahren zu deren herstellung und deren verwendung
DE60105314D1 (de) Verfahren zur herstellung von taxanderivaten
AU2001228468A1 (en) Working up a mixture comprising alkene and oxygen
ATE356110T1 (de) Verfahren zur herstellung von kristallinem cholinascorbat
DE50209497D1 (de) Methode zur herstellung von magnesiumdiborid sowie von magnesiumdiborid-formkörpern aus magnesiumhydrid und elementarem bor mittels puls-plasma-synthese
DE60235820D1 (de) Verfahren zur herstellung von azoverbindungen
WO2004024681A3 (fr) NOUVEAUX COMPOSES COMPRENANT UN GROUPEMENT THIOCARBONYLSULFANYLE UTILES POUR LA SYNTHESE DE COMPOSES α-PERFLUOROALKYLAMINES PAR VOIE RADICALAIRE
DE50109832D1 (de) Verfahren zur herstellung von essigsäure

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties